CClinicalTrials.gg
CompletedNCT07098689BEM-02Updated Aug 1, 2025

Body Emotional Map Method for the Reduction of Parental Stress Related to Diabetes

An interventional study of The BEM (Body Emotional Maps) program and Control group in Stress (Psychology) and Diabete Type 1, sponsored by Valentino Cherubini. Completed at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-01.

Sponsored by Valentino Cherubini · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Apr 2024, registered Jul 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
139
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the impact of the BEM method on stress and well-being in parents of children/adolescents with type 1 diabetes, compared to a standard group approach focused on therapeutic education (control group). The BEM Program involves an experiential, group-based approach facilitated by 2-3 trained facilitators and a maximum of 25 parent participants. Each session takes place over three consecutive days and includes both plenary sessions with the entire group and smaller subgroup activities. Metodology of BEM approach includes: relaxation techniques, breathing exercises, and guided visualizations NLP (Neuro-Linguistic Programming) techniques: spatial anchoring, Time Line therapy, and future pacing. Approaches based on Transactional Analysis (T.A.) and Systemic-Relational frameworks, brief interventions focused on problem-solving. Techniques for enhancing bodily and emotional awareness. Interactive group discussions. The control intervention will take place during a camp specifically dedicated to parents, with the same duration as the BEM program. The intervention includes educational and informational sessions on key aspects of type 1 diabetes management (management of acute complications, importance of glycemic indices, carbohydrate counting, current and emerging perspectives in type 1 diabetes care). In addition, the program includes opportunities for parents to share personal experiences and participate in recreational activities.

02

Conditions studied

  • Stress (Psychology)
  • Diabete Type 1

Keywords

  • BODY EMOTIONAL MAP
  • PARENTAL STRESS
  • chronic condition
  • Type 1 diabetes
03

In context

Chronic Disease

990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.

This study's enrollment of 139 is above the median of 120 across 722 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

This is the only study on the registry with Valentino Cherubini as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Parents of children and adolescents under 18 years of age with type 1 diabetes duration exceeding 12 months;
  • Parents of children who have never been diagnosed with psychiatric or behavioral disorders;
  • Adequate understanding of the Italian language, as assessed by the clinician;
  • Parents willing to: Actively participate in group experiential activities; Complete the required questionnaires; Signed informed consent from the participating individual; Signed informed consent for data processing of the minor by both parents (if applicable).

Exclusion criteria

Exclusion Criteria:

Parents:

  • with psychiatric conditions
  • of patients with psychiatric issues or behavioral disorders
  • with any problem that, according to the clinician's judgment, would prevent active participation in group experiential activities
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
139 participants (actual)

Study arms

  • Experimental
    BEM group

    In the BEM group, participants will receive basic information on diabetes management through external resources (medical support, technology, telemedicine, carbohydrate counting techniques) and internal resources (learning effective techniques and behaviors to improve metabolic control).

    Other: The BEM (Body Emotional Maps) program

  • Active comparator
    Control group

    In the control group, basic information on diabetes management will be provided through external resources (medical support, technology, telemedicine, carbohydrate counting techniques) and internal resources (learning effective techniques and behaviors to improve metabolic control).

    Other: Control group

Interventions

  • OtherThe BEM (Body Emotional Maps) program

    The BEM method involves an intervention with the parents of children with diabetes, conducted in group settings, aimed at facilitating parents' adaptation to their child's "diabetes condition". The BEM method involves an intervention with the parents of children with diabetes, conducted in group settings, aimed at facilitating parents' adaptation to their child's "diabetes condition". The intervention is organized into three sessions. The first session consists of an introduction and group formation. The second session involves sharing the onset of diabetes, identifying the most critical daily challenges, and the primary change the participants wish to implement. The third session features the BEM pathway, which includes guided visualization and the creation of a map with spatial anchors.

  • OtherControl group

    The control group will receive the same diabetes management information, accompanied by parent discussion sessions and recreational activities guided by the diabetes team staff. As with the BEM group, activities will take place over three days in an off-hospital location, in contact with nature.

06

What researchers measure

Primary outcomes

  1. Difference in PSI-SF (Parental Stress Index Short-Form) scores after 3 months

    The primary endpoint is represented by the difference in PSI-SF (Parental Stress Index Short-Form) scores after 3 months of participation in the group activities compared to baseline. PSI-SF subscale scores range from 12 to 60, and the total score from 36 to 180. High subscale scores and a high PSI-SF total score indicate higher levels of stress. Responses above the 85th percentile are considered clinically significant.

    Time frame: From enrollment to 3 months after the participation in the BEM activities

Secondary outcomes

  1. Difference in PSI-SF (Parental Stress Index Short-Form) scores after 6 months and in the scores of the individual components of the PSI-SF questionnaire

    The secondary endpoint is represented by the difference in PSI-SF (Parental Stress Index Short-Form) scores (total and of each suscale) after 6 months of participation in the group activities compared to baseline. Subscale scores range from 12 to 60, and the total score from 36 to 180. High subscale scores and a high PSI-SF total score indicate higher levels of stress. Responses above the 85th percentile are considered clinically significant.

    Time frame: from enrollment to 6 months from participation in the group activities compared to baseline

  2. Patient Health Questionnaire (PHQ-9)

    Difference in the scores of the Patient Health Questionnaire (PHQ-9) for the assessment of depression and depressive symptoms after 3 and 6 months from the baseline. Each symptom is rated on a 4-point scale. Scores range from 0 to 27, with different levels of depression severity depending on the score: 10-14 = Mild major depression; 15-19 = Moderate major depression; ≥ 20 = Severe major depression.

    Time frame: From enrollment to 3 and 6 months from participation in the group activities compared to baseline

  3. General Anxiety Disorder (GAD-7)

    Difference in the scores of the General Anxiety Disorder (GAD-7) questionnaire for the assessment of anxiety and anxious symptoms. Scores of 0, 1, 2, or 3 are assigned for symptoms occurring "not at all," "several days," "more than half the days," and "almost every day," respectively. The scores are then summed and range from 0 to 21. Scores of 5, 10, and 15 represent cutoffs for mild, moderate, and severe anxiety, respectively.

    Time frame: From enrollment to 3 and 6 months from participation in the group activities compared to baseline.

  4. Brief Pittsburgh Sleep Quality Index (B-PSQI)

    Difference in the scores of the Brief Pittsburgh Sleep Quality Index (B-PSQI) for the assessment of sleep disturbances. For each area, a score from 0 (highest positive) to 3 (lowest negative) is assigned, as follows: "Never during the last month" = 0; "Less than once a week" = 1; "1 or 2 times a week" = 2; "3 or more times a week" = 3. Summary score is then generated, obtained by adding the scores for the individual areas, with a value ranging from 0 to 21. Score between 5 and 7 indicates mild sleep disturbances may occur; score above 7 indicates that it is recommended to consult a doctor for a more in-depth evaluation of sleep disturbances.

    Time frame: From enrollment to 3 and 6 months from participation in the group activities compared to baseline

  5. Parental Self-Efficacy for the Management of Diabetes Mellitus (PSESDM) questionnaire.

    Difference in the scores of the Parental Self-Efficacy for the Management of Diabetes Mellitus (PSESDM) questionnaire for the evaluation of self-efficacy perception in managing their child's diabetes. Responses range from 1 = "Strongly disagree" to 5 = "Strongly agree." Items 1, 2, 6, and 7 are reverse-scored. The total score on the measure ranges from 8 to 40. A higher score on the PSESDM represents greater parental confidence in managing their child's diabetes.

    Time frame: From enrollment to 3 and 6 months from participation in the group activities compared to baseline

  6. Coping Orientation to the Problems Experienced - Italian Version (COPE-NVI)

    Difference in the scores of the Coping Orientation to the Problems Experienced - Italian Version (COPE-NVI) questionnaire for assessing parental adaptation and coping strategies. Responses to each question are given on a scale from 1 = "I usually don't do it" to 4 = "I almost always do it." Individual question scores are summed separately for each of the 5 areas.

    Time frame: From enrollment to 3 and 6 months from participation in the group activities compared to baseline

  7. Glucometric data of children/adolescents

    Difference in glucometric data of children/adolescents: * HbA1c; if CGM, glucose values in the last 15 days: * Time in Range; * Time below range level 1; * Time below range level 2; * Time above range level 1; * Time above range level 2, * Average blood glucose.

    Time frame: From enrollment to 3 and 6 months from participation in the group activities compared to baseline.

07

Study locations

1 site
  • Department of Women's and Children's Health Azienda Ospedaliero Universitaria delle Marche, G. Salesi Hospital
    Ancona, 60123, Italy
08

References and documents

Study documents

  • Study protocol · Jul 26, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07098689
Lead sponsor
Valentino Cherubini
Responsible party
Valentino Cherubini (Head of Unit, Paediatric Diabetology Department of Women's and Children's Health "G. Salesi Hospital", AOU OORR Ancona, Via F. Corridoni, 11 60123 Ancona, Italy, Ospedali Riuniti Ancona) — Sponsor-investigator
First posted
Aug 1, 2025
Start date
Apr 11, 2024
Primary completion
Mar 15, 2025
Completion
Jun 12, 2025
Last update
Aug 1, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion